This biopharmaceutical company has 14 marketed products and over 4200 employees on four continents. Gilead had almost $8 billion in revenues in 2010.
Gilead Sciences consistently ranks among top performers in the Wealth Creation Index. Among the consistent top performers, Mike Burdi, Applied Finance Group senior analyst, finds a common thread: “Do your customers care whether you stay in business? It’s one thing to say that one is customer-focused; most claim to be as a matter of course. But would your customers really miss not having access to what you offer?” For Gilead customers, that answer is yes.
| Score | 2010 Score | % Change In Score | Market Value/Invested Capital | Three-Year EM | EM Change | Mgmt Quality |
|---|---|---|---|---|---|---|
| 92.8 | 86.7 | 7.0% | B | A | A | A |
When work swallows everything, it’s not a badge of honor—it’s a warning. In this week’s…
How Shivani Dhamija shut down a failing concept, pivoted to packaged foods and built Shivani’s…
A new survey examines how public and private companies manage short-term demands against long-term strategy—and…
Leading through economic turbulence often forces CEOs to make painful trade-offs. In Everybody Matters: The…
Advances from next-generation chips and quantum technologies to cutting-edge energy storage are cementing the region’s…
At Chief Executive’s 2025 CEO of the Year celebration, a cross-industry roundtable of business leaders…